ArticlePloS one2017
High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer.
Christina Siesing et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it